Quick Answer
TANDEM DIABETES CARE INC reported Revenue (ASC 606) of $1.01 billion for fiscal year 2025.
TANDEM DIABETES CARE INC Revenue (ASC 606) — Annual History
| Fiscal Year | Revenue (ASC 606) | YoY Change |
|---|---|---|
| 2025 | $1.01B | +7.9% |
| 2024 | $940.20M | +25.7% |
| 2023 | $747.72M | -6.7% |
| 2022 | $801.22M | +14.0% |
| 2021 | $702.80M | +40.9% |
| 2020 | $498.83M | +37.7% |
| 2019 | $362.31M | +97.0% |
| 2018 | $183.87M | +70.9% |
| 2017 | $107.60M | +27.7% |
| 2016 | $84.25M | — |
Quarterly Revenue (ASC 606)
| Quarter Ending | Revenue (ASC 606) | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $249.25M | +2.2% | +3.6% |
| June 30, 2025 | $240.68M | +8.5% | +2.7% |
| March 31, 2025 | $234.42M | +22.3% | -3.9% |
| September 30, 2024 | $243.97M | +31.4% | +9.9% |
| June 30, 2024 | $221.91M | +13.3% | +15.8% |
| March 31, 2024 | $191.67M | +13.2% | +3.3% |
| September 30, 2023 | $185.62M | -9.3% | -5.3% |
| June 30, 2023 | $195.92M | -2.2% | +15.7% |
- TANDEM DIABETES CARE INC showed an increase of +7.9% in Revenue (ASC 606) compared to the prior fiscal year.
- Over the 2016–2025 period, TANDEM DIABETES CARE INC’s revenue (asc 606) has grown by 1104.5% (from $84.25 million to $1.01 billion).
- The most recent figure is from TANDEM DIABETES CARE INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 19, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: